tion, the plates were washed extensively with TBS containing Tween alone. Bound antibodies were detected with alkaline phosphatase-conjugated anti-mouse IgM or IgG using p-nitrophenylphosphate (Sigma Chemical Co., St . Louis, MO) as a substrate. Antibody levels were expressed as the absorbance at 405 nm (Aa0s) (ImmunoReader; Nippon InterMed, Tokyo, Japan) .
Histology. Main organs from 6-mo-old CBA-m mice were fixed in l0olo formalin in PBS, embedded in paraffin, sectioned at 4 km, and stained with hematoxylin and eosin for histologic examination .
Results 1 yr Follow-up of CBA-m Mice. 36 males and 26 females from the CBA-m colony under SPF conditions were observed for the development of lymphadenopathy and mortality up to 1 yr of age. In all mice, the enlargement of superficial lymph nodes commenced at -2 .5 mo of age with a tendency of earlier onset in cervical than in inguinal lymph nodes, and splenomegaly was clearly palpable after 3 mo of age. The first death was recorded at 19 and 29 wk of age, and the survival rate at 1 yr of age was 61 .1 and 46 .2% in males and females, respectively ( Fig . 1 ) . All nonmutant counterparts survive >1 yr under similar conditions.
CBA-m mice with the above macroscopic pathological characters were used in genetic studies. Breeding tests involving Ft, F2, and backcross mice were conducted in order to clarify the genetic control of the mutant trait. Practically the same results were obtained with regard to the development and progression of lymphadenopathy in the crosses of mutant males with normal females, and in the reverse crosses, demonstrating the autosomal inheritance of the disease. Thus, the pooled results from the reciprocal crosses are presented in the tables .
Lymphadenopathy in FI Progeny. 30, 86, 21, 4, 26, 37, and 32 male and female Fi mice were obtained by mating CBA-m to B6-+, CBA-+, C3H-+, DDD-nu, MRL-+, NZW-+, or SWR + mice, respectively, and observed for the presence or absence of enlarged lymph nodes and splenomegaly by palpation for a 5-6-mo period and by autopsy at the end of this period, since the prolonged observation up to 1 yr of age had been confirmed to have no influence on the outcome in (CBA-m x CBA-+)Fi mice. None of the total number of 236 FI mice showed any sign of lymphoid hyperplasia in support of the recessive nature of the mutation .
Lymphadenopathy in F2 Progeny. F2 mice derived from the combinations of CBAm x B6-+, CBA-m x CBA-+, CBA-m x C3H-+, CBA-m x MRL-+, and CBAm x NZW-+ were observed as mentioned above (Table I) 16 and 52 in (CBA-m x MRL-+)F2, and 13 and 39 in (CBA-m x NZW +)F2, respectively. When these results were combined, 121 F2 mice were affected by the hereditary disease, but 356 were normal. The ratio of the diseased to nondiseased mice was 1 :2 .94. Therefore, the hereditary disease was verified to be transmitted by a single autosomal recessive gene in accordance with the mendelian law.
Lymphadenopathy in Backsross Progeny. (CBA-m x B6-+)Fl and (CBA-m x CBA-+)F1 were backcrossed to CBA-m mice, and their offspring were observed as mentioned above (Table II) . In the former backcross, 108, but not 92, mice developed obvious lymphadenopathy. The latter gave a similar result : 50, but not 53, mice had enlarged lymph nodes and spleens. Collectively, 158, but not 145, backcross mice were hereditarily diseased . Their ratio was 1 :0 .92. This result also supports the above conclusion, the single autosomal recessive gene control. Allelism of the Mutant Gene with gld, lpr, and Yaa. So far, three mutant genes, gld, lpr, and Yaa, have been reported to be involved in lymphadenopathy with autoimmune disease in mice (1) (2) (3) (4) (5) . Since the Yaa gene is linked to Y chromosome (1, 4, 5) , the new mutant gene is clearly considered to be different from it. Both gld and lpr are autosomal recessive genes (1) . The former is mapped on chromosome 1 (3, 15) , but the genetic linkage of the latter has not been established, despite the fact that 47 % of the autosomal genomes has been tested (2, 16) . Lymph node and spleen enlargements in mice homozygous for either gene progressed in a similar course as in the mutant mice . Therefore, a question arose as to whether the mutant gene is allelic with gld or lpr, or is different from both. To answer the question, 101 (CBAm x C3H-gld)F1 , 77 (CBA-m x C3H-lpr)Fj, and 30 (CBA-m x MRL-lpr)Fi mice were observed for the development of lymphadenopathy as mentioned above. Contrary to our expectations, all these hybrids developed palpable and visible lymphadenopathy (Table III) , although the lymph node and spleen enlargements were smaller in severity in (CBA-m x C3H-gld)Fl mice. All (C3H-gld x C3H-lpr)Fl mice were completely free from illness in palpation and at autopsy, in accord with the different allelism ofgld and lpr (2) . All other control hybrids were negative for lymphadenopathy. To further analyze the allelism of the mutant gene with gld or lpr, backcrossing tests were conducted between CBA-+, C3H-+, CBA-m, or C3H-gld and (CBA-m x C3H-gld)F,, and between CBA-+ or CBA-m and (CBA-m x C3H-lpr)Fi mice (Table IV) (Table IV) . It is, therefore, very reasonable to conclude that the mutant gene may be allelic with or lie on the same chromosome in close proximity to lpr. The former possibility is more likely, since the mutant gene and lpr can be estimated to exist within 0.62 cM from the absence of crossing over in the sum total of 322 backcross mice .
In conclusion, the new mutant gene is considered to be allelic with lpr, but able to complement gld in induction of lymphadenopathy, and therefore is named lpr'g (lpr complementing gld) .
Comparison of Lymphoproliferation among gld/gld, lpr/lpr, lpt`e/lpr`g lpr/lpr`g, and +/ gld +/lpr'9 (gld-lpr'g) Genotypes. The course of lymphoproliferation was investigated by weight measurements of lymph nodes and spleens in CBA-m, C3H-gld, C3H-lpr, (CBA-m x C3H-gld)Fj, and (CBA-m x C3H-lpr)Fl mice (Table V) . In CBA-m mice, the superficial lymph nodes and spleens commenced to enlarge at 2 mo of age, and the internal lymph nodes did so at 3 mo of age. Lymphadenopathy became more severe with age. However, the mesenteric lymph nodes did not show marked hyperplasia. At 5 mo of age, the profile of lymphoproliferation was practically the same in CBA-m, C3H-gld, C3H-lpr, and (CBA-m x C3H-lpr)Fl mice, except for the normal size of mesenteric lymph nodes in the first. In contrast, lymph node hyper- 
The weight of a lymph node was expressed as <5 mg when it was normal (see the text) . Therefore, the combined superficial and internal lymph node weights are <50 and <40 mg, respectively, when all lymph nodes are normal in size .
t Mean t SE . The value with or without ± SE means that some or all lymph nodes were normal, respectively .
plasia and splenomegaly were of significantly lesser severity in (CBA-m x C3H-gld)F1 mice . The superficial lymph nodes were >5 and >15 times heavier than the normal ones at 3 and 5 mo of age, respectively, but the internal lymph nodes and spleen were practically normal and sporadically hyperplastic, respectively. More interestingly, although lymphoproliferation was generally progressive after 5 mo of age in CBA-m, C3H-gld, C3H-lpr, and (CBA-m x C3H-lpr)Fl mice (data not shown), it became far less severe at 10 and 12 mo of age in (CBA-m x C3H-gld)F1 . Hyperplasia was sporadic even in the superficial lymph nodes, and all internal lymph nodes were normal in size in many mice, suggesting regression of lymphadenopathy. In addition, the peripheral leukocyte count at 5 mo of age was in the normal range in (CBA-m x C3H-gld)F,, but abnormally higher in the other mice (data not shown) . These findings support the conclusion of the genetic studies that the mutant gene, lpr'g, is allelic with lpr but nonallelic with gld.
Comparison of Surface Antigens of Lymph Node Cells among gld/gld, lpr/lpr, lprc911prc9, lpr/lpr'g, and gld-lpr'g Genotypes. Lymph node cells from 5-6-mo-old mice with these 5 genotypes were examined for their reactivity to a panel of antibodies (Table VI) . As expected from the genetic studies, the proportions of cells positive for sIg, Ly-5(B220), Thy-1, Lyt-2, and L3T4 were essentially the same in gld/gld, lpr/lpr, lpr'911pi1g, lpr/lprrg, and gld-lpr'g mice . As already reported in C3H-gld and C3H-lpr (7), CBA-m mice were also characterized by the major population of Thy-1 +, Ly-5(B220)+, Lyt-2 -, L3T4 -cells in enlarged lymph nodes, as compared with CBA-+ and C3H-+ normal mice . The presence of such anomalous lymphoid cells was further confirmed by two-color flow cytometric analyses (data not shown) . The results indicate that the combination of gld-lpr`g can induce the anomalous differentiation of T cells as do gld/gld, lpr/lpr, and lpr`g/lpr`g. Serum Ig andAnti-DNA Antibody Levels. Hyperimmunoglobulinemia and antinuclear antibodies are the important characters of mice homozygous for lpr or gld. As expected from the genetic studies, serum IgM and IgG levels, and anti-ssDNA and anti-dsDNA antibody titers, were abnormally higher in CBA-m (Table VII) , as in C3H-gld (3) and MRL-lpr mice (4) . Moreover, the anti-ssDNA antibody titer was compared among normal, mutant, and hybrid mice (Table VIII) . It was significantly higher in CBA-m, (CBA-m x C3H-lpr)F1 , C3H-lpr, and C3H-gld mice, which developed massive lymphoid hyperplasia but remained at insignificant or very low levels in (CBA-m x C3H-gld)F1 , with slighter lymphadenopathy and the other normal or hybrid mice completely free from the disease. This supports the genetic conclusion that lpr'g is allelic with lpr but not with gld.
Histological Examination of CBA-m Mice. Infiltration of lymphoid cells were frequently seen in the livers, lungs, and kidneys from 6-mo-old CBA-m mice. However, these organs had no pathologic lesions characteristic of autoimmune disease, and were especially free from interstitial pneumonitis reported in C3H-gld (3), and glomerulonephritis and vasculitis reported in MRL-lpr (17) . The absence of renal pathologic lesions might be due to the CBA background genes, since renal and vascular diseases were found in some of lpr19 mice considered to have 75% or more MRL genetic background (data not shown) . This also supports the conclusion that lprrg is a new allele of the lpr locus. The basic histopathological and immunopathological features of CBA-m mice are reported in greater detail elsewhere (18) . 
Discussion
Autoimmune mice homozygous for lpr or gld develop massive lymphoproliferation and associated autoimmune processes leading to autoantibody production and autoimmune kidney disease (2, 3, 19) . Although gld and lpr are not allelic (1-3) , a large body of evidence has accumulated to demonstrate that both genes have many anomalous phenotypic manifestations in common : (a) most lymphoid cells from enlarged lymph nodes are Thy-1+, Ly-1+, Lyt-2 -, L3T4 -, Ly-5(8220)+, Ly-6+, Ly-22+, Ly-24+, sIg-, ThB-, la -, HSA", and PC .1+ (7, 20, 21) ; (b) the anomalous cells show the same profile of binding lectins (7); (c) they are refractory to stimulation with antigen or mitogen and do not produce IL-2 or IFN-'Y (7, (22) (23) (24) ; (d) spleen and lymph node cells produce high levels of c-myb RNA (22, 23) ; and (e) serum IgM, IgG, and IgA levels and anti-ssDNA and anti-dsDNA antibody titers are elevated (2, 3, 24) . In addition, the xid gene has similar modifying effects on both genes (25) . Based on these striking parallels between phenotypes of the two nonallelic genes, it has been suggested that gld and lpr may represent alterations in two different enzymes that act in a common metabolic pathway of major inportance to T cell differentiation and function (7, 20) .
The mutant mice (CBA-m) reported here also develop massive lymphadenopathy similar in severity and profile of lymph node hyperplasia and splenomegaly to that in gld or lpr homozygotes (Table V) . Genetic studies have provided evidence that the mutation is a single autosomal recessive gene like gld and lpr, which are not allelic with each other (Tables I and II) . To our surprise, however, this gene interacted with either gldor lpr to induce lymphoproliferation (Table III) . Further genetic analyses demonstrated that the mutant gene is not allelic with gld but exists within 0.62 cM on the same chromosome or is allelic with lpr (Table IV) . Thus, the mutant gene was named lp7'9, an lpr gene complementing gld in induction of lymphoproliferation.
The conclusion of the genetic studies has been supported by many phenotypic features common to gld/gld, lpr/1pr, lp?'9/lprcB, lpr/lpr'g, and gld-lpr'g genotypes. Lym- phoid cells from enlarged lymph nodes of C3H-gld, C3H-lpr, CBA-m, (CBA-m x C3H-gld)Fi, and (CBA-m x C3H-lpr)Fi mice showed the same profile of surface markers: Thy-1+, Ly-1+, Lyt-2-, L3T4-, Ly-5(B220)+, Ly-6+, Ly-24+, sIg, and la- (Table VI and (Table V) , and antinuclear and anti-DNA antibody levels were abnormally high in the first four strains of mice, but in the normal range in the last (18) ( Table VIII) . These findings are reasonable in the light ofthe distinct allelism of lpr'g with gld, and they suggest that the cooperation between lpr'g and g1d may be sufficient to develop anomalous T cells but insufficient to induce autoantibodies, and that the anomalous lymphocytes in massively enlarged lymph nodes may have an important role in autoantibody formation. In terms ofgld-Ipfg interaction, it is of great interest that 1pr has been shown not to be totally recessive, since some B cell hyperactivity is expressed in a heterozygous state (28) . It may be possible that lp~g functions in a heterozygous state to produce a protein that may be slightly different from the product of 1pr and can effect gld. The discovery of the lpfg gene in CBA mice has provided strong evidence for the similarities between the syndromes induced by gld and lpr, and strongly suggests that both genes may influence the same point of a common metabolic pathway of major importance to the differentiation and function ofT cells. We believe that CBAlpr`g mice will provide an experimental material vital to elucidation at the molecular and gene levels of the mechanism by which gld and lpr induce the abnormal differentiation and functions of lymphocytes in mice. Summary Several mice with generalized lymphadenopathy were found in the CBA/K1Jms (CBA) colony maintained at our institute. A new mutant strain ofmice that develop massive lymphoid hyperplasia at 100% incidence within 5 mo after birth was established by crossing these diseased mice . Genetic studies on lymphadenopathy were conducted in Fl, F2, and backcross populations from crosses between mutant CBA (CBA-m) and various inbred strains of mice . The results supported the control of lymphadenopathy by a single autosomal recessive gene. Since C3H/Hegld/gld (C3H-gld), MRL/MpJ-lpr/lpr (MRL-1pr), and C3H/HeJ-lpr/lpr (C3H-lpr) mice develop the same type of lymphoid hyperplasia, allelism of the mutant gene with g1d or lpr was tested by investigating lymphadenopathy in Fi and backcross populations from crosses between CBA-m and C314-gld, MRL-lpr, or C3H-lpr mice. The gene was confirmed to be allelic with lpr but not with gld. Interestingly, however, the mutant gene interacted with g1d to induce less severe lymphadenopathy. Thus, the mutant gene was named lpr'g, an lpr gene complementing gld in induction of lymphoproliferation. The genetic conclusion was supported by the same profile of surface markers of lymphoid cells with gld/gld, lpr/lpr, lp7C9/lprCB, lpf9/lpr, and +/gld +/lpr'9 genotypes, as well as by massive lymph node hyperplasia and high titers of autoantibodies in the first four genotypes, but slight hyperplasia and insignificant autoantibody production in the last. The discovery of lpr19 provided strong genetic evidence for the parallels between anomalous phenotypes of gld and lpr, and CBA/K1Jms-lpr`g/lpf9 mice will contribute to elucidation of the mechanism of induction of the same abnormal differentiation and functions of lymphocytes by gld and lpr .
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